Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions

被引:4
|
作者
Wand, Alison L. [1 ]
Russell, Stuart D. [2 ]
Gilotra, Nisha A. [1 ]
机构
[1] Johns Hopkins Univ, Dept Med, Div Cardiol, Sch Med, 600 N Wolfe St,Carnegie Suite 568, Baltimore, MD 21287 USA
[2] Duke Univ, Dept Med, Div Cardiol, Sch Med, Durham, NC USA
来源
HEART INTERNATIONAL | 2021年 / 15卷 / 01期
关键词
Heart failure; worsening heart failure; ambulatory treatment; outpatient treatment; remote monitoring; telemonitoring; intravenous diuretics; subcutaneous diuretics; INTRAVENOUS DIURETIC THERAPY; SUBCUTANEOUS FUROSEMIDE; LOOP DIURETICS; CARE; COVID-19; IMPACT; HOSPITALIZATION; MORTALITY; OUTCOMES; ALGORITHM;
D O I
10.17925/HI.2021.15.1.49
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is a highly prevalent and morbid disease in the USA. The chronic, progressive course of HF is defined by periodic exacerbations of symptoms, described as 'worsening heart failure' (WHF). Previously, episodes of WHF have required hospitalization for intravenous diuretics; however, recent innovations in care delivery models for patients with HF have allowed a transition from the acute care setting to the ambulatory setting. The development of remote monitoring strategies, including device-based algorithms and implantable haemodynamic monitoring systems, has facilitated more advanced surveillance of patients, aiming to prevent the clinical deterioration that leads to hospitalization. Additionally, the establishment of multidisciplinary HF clinics has provided the setting and resources for the outpatient treatment of WHF, specifically the administration of intravenous diuretics. Here we review the current state of ambulatory HF management, including mechanisms for patient monitoring and treatment, and outline future opportunities for outpatient management of this patient population.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [1] Surgical Treatment of Heart Failure: current repair strategies and future directions
    Maltais, S.
    Perrault, L. P.
    NEW HORIZONS IN CARDIOVASCULAR DISEASES, 2010, : 169 - 175
  • [2] Current treatment and future directions in heart failure
    Wells, G
    Little, WC
    CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (02) : 148 - 153
  • [3] Using Biomarkers to "Guide" Heart Failure Management: Current Perspectives and Future Directions
    Motiwala, Shweta R.
    Januzzi, James L., Jr.
    CARDIOLOGY IN REVIEW, 2013, 21 (03) : 127 - 134
  • [4] Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions
    Bharathi Upadhya
    Dalane W. Kitzman
    American Journal of Cardiovascular Drugs, 2017, 17 : 283 - 298
  • [5] Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions
    Upadhya, Bharathi
    Kitzman, Dalane W.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (04) : 283 - 298
  • [6] Update on heart failure management and future directions
    Choi, Hong-Mi
    Park, Myung-Soo
    Youn, Jong-Chan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (01): : 11 - 43
  • [7] Heart failure with preserved ejection fraction: current management and future strategies
    Tschoepe, Carsten
    Birner, Christoph
    Bohm, Michael
    Bruder, Oliver
    Frantz, Stefan
    Luchner, Andreas
    Maier, Lars
    Stoerk, Stefan
    Kherad, Behrouz
    Laufs, Ulrich
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (01) : 1 - 19
  • [8] Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review
    Krittanawong C.
    Kukin M.L.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (4)
  • [9] Pharmacological management of migraine: current strategies and future directions
    Pellesi, Lanfranco
    Do, Thien Phu
    Hougaard, Anders
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (06) : 673 - 683
  • [10] Advancing heart failure management: innovations and future directions
    Lancellotti, Patrizio
    Ancion, Arnaud
    ACTA CARDIOLOGICA, 2024, 79 (08) : 861 - 865